State Of Wisconsin Investment Board Athenex, Inc. Transaction History

State Of Wisconsin Investment Board

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.36 - $2.94 $133,824 - $289,296	-98,400 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$11.06 - $14.01 $217,882 - $275,997	-19,700 Reduced 16.68%	98,400 $1.09 Million
Q3 2020 Nov 16, 2020	BUY	$10.26 - $14.55 $114,912 - $162,960	11,200 Added 10.48%	118,100 $1.43 Million
Q2 2020 Aug 12, 2020	BUY	$7.11 - $13.76 $10,665 - $20,640	1,500 Added 1.42%	106,900 $1.47 Million
Q1 2020 May 06, 2020	BUY	$5.71 - $15.85 $94,786 - $263,110	16,600 Added 18.69%	105,400 $816,000
Q3 2019 Nov 12, 2019	BUY	$12.16 - $21.0 $347,776 - $600,600	28,600 Added 47.51%	88,800 $1.08 Million
Q2 2019 Aug 14, 2019	BUY	$9.44 - $19.8 $12,272 - $25,740	1,300 Added 2.21%	60,200 $1.19 Million
Q1 2019 May 13, 2019	BUY	$11.11 - $13.49 $149,985 - $182,115	13,500 Added 29.74%	58,900 $722,000
Q4 2018 Feb 11, 2019	BUY	$10.24 - $15.49 $25,600 - $38,725	2,500 Added 5.83%	45,400 $576,000
Q2 2018 Aug 03, 2018	BUY	$15.88 - $19.5 $681,252 - $836,550	42,900 New	42,900 $801,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.